Intellectual property is arguably the lifeblood of discovery. But as academic scientists increasingly accept industry funding and engage in commercial activities such as patenting, the concern is that biomedical research will suffer as rights holders refuse to share their materials and information. Patents, however, may not be the issue, according to two recent surveys and a new report by the National Academy of Sciences.1
Advertisement
Survey Series
For Advertisers